Kura Oncology Ownership | Who Owns Kura Oncology?
Kura Oncology Ownership Summary
Kura Oncology is owned by 94.66% institutional investors, 1.05% insiders, and 4.29% retail investors. Suvretta capital management is the largest institutional shareholder, holding 8.43% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.75% of its assets in Kura Oncology shares.
KURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kura Oncology | 94.66% | 1.05% | 4.29% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 7.07M | 8.43% | $145.56M |
| Blackrock | 6.97M | 8.30% | $143.43M |
| Deerfield management company, l.p. (series c) | 5.41M | 6.45% | $111.42M |
| Paradigm biocapital advisors lp | 4.54M | 5.41% | $93.47M |
| Bvf inc/il | 4.08M | 4.87% | $84.05M |
| Vanguard group | 4.04M | 4.82% | $83.19M |
| Avoro capital advisors | 3.54M | 4.22% | $72.92M |
| State street | 2.88M | 3.44% | $59.39M |
| Holocene advisors, lp | 2.69M | 3.21% | $55.38M |
| Armistice capital | 2.35M | 2.80% | $48.39M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Foresite capital management iv | 1.85M | 25.59% | $38.09M |
| Suvretta capital management | 7.07M | 5.35% | $145.56M |
| Alethea capital management | 265.91K | 4.15% | $5.48M |
| Prosight management, lp | 629.90K | 3.88% | $12.97M |
| Ally bridge group (ny) | 306.76K | 3.76% | $6.32M |
| Paradigm biocapital advisors lp | 4.54M | 3.58% | $93.47M |
| Tcg crossover management | 1.42M | 3.06% | $29.31M |
| Acuta capital partners | 163.00K | 2.83% | $3.36M |
| Exome asset management | 131.74K | 2.42% | $2.71M |
| Bvf inc/il | 4.08M | 2.36% | $84.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 4.54M | 3.58% | 1.40M |
| Assenagon asset management | 1.73M | 0.08% | 577.73K |
| Deep track capital, lp | 384.76K | 0.24% | 384.76K |
| Sofinnova investments | 825.24K | 0.88% | 323.30K |
| Armistice capital | 2.35M | 0.61% | 302.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 2.88M | 0.00% | -1.32M |
| Bvf inc/il | 4.08M | 2.36% | -704.26K |
| Ecor1 capital | - | - | -700.00K |
| Dimensional fund advisors lp | 894.62K | 0.00% | -468.82K |
| Prosight management, lp | 629.90K | 3.88% | -330.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deep track capital, lp | 384.76K | 0.24% | 384.76K | $7.92M |
| Ameriprise financial | 182.56K | 0.00% | 182.56K | $3.76M |
| Woodline partners lp | 143.21K | 0.03% | 143.21K | $2.95M |
| Exome asset management | 131.74K | 2.42% | 131.74K | $2.71M |
| Eversept partners, lp | 72.32K | 0.10% | 72.32K | $1.49M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Quantbot technologies lp | -14.00 |
| Main street group | -50.00 |
| Innealta capital | -54.00 |
| Pacer advisors | -709.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 183 | 2.23% | 82,304,529 | 2.31% | 94 | 1.03% | 82 | -2.38% | 56 | -9.68% |
| Jun 30, 2024 | 179 | 4.68% | 80,450,005 | -0.33% | 95 | 1.04% | 84 | -11.58% | 62 | 31.91% |
| Mar 31, 2024 | 171 | 20.42% | 80,714,791 | 2.51% | 96 | 0.93% | 95 | 33.80% | 47 | 9.30% |
| Dec 31, 2023 | 142 | 5.97% | 78,740,296 | 4.56% | 101 | 1.07% | 71 | -4.05% | 43 | 30.30% |
| Sep 30, 2023 | 134 | -12.99% | 75,309,454 | 0.24% | 97 | 0.84% | 74 | -9.76% | 33 | -19.51% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.14M | 2.75% | -27.36K |
| iShares Russell 2000 ETF | 1.87M | 2.41% | -4.21K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.19M | 1.55% | -2.56K |
| SPDR® S&P Biotech ETF | 1.01M | 1.32% | 11.19K |
| Fidelity Small Cap Index | 742.43K | 0.97% | -19.96K |
| Franklin US Small Cap Growth Equity | 679.12K | 0.89% | -6.98K |
| Franklin Small Cap Growth Adv | 679.12K | 0.89% | - |
| iShares Russell 2000 Growth ETF | 645.05K | 0.83% | - |
| Franklin Biotechnology Discv A(acc)USD | 533.90K | 0.70% | - |
| HBM Healthcare Investments AG Ord | 500.00K | 0.65% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 18, 2024 | FORD KATHLEEN | Chief Operating Officer | Sell | $8.43K |
| May 20, 2024 | Bair Teresa Brophy | Chief Legal Officer | Sell | $57.92K |
| Jan 29, 2024 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $13.55K |
| Jan 29, 2024 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $17.14K |
| Jan 29, 2024 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $10.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 9 |
| 2023 Q4 | - | - |
KURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools